InsiderTrades

Form 4 for KNSA Kiniksa Pharmaceuticals International, plc

Accepted 2025-08-14 00:00:00 ET · period of report 2025-08-12 · accession 0001415889-25-021941 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-14 2025-08-12+ KNSA Malley Thomas Dir M - OptEx $10.21 +177.8K 62.0K New +$1.82M
DM 2025-08-14 2025-08-12+ KNSA Malley Thomas Dir S - Sale+OE $32.96 -177.8K 12.5K -93% -$5.86M
DM 2025-08-14 2025-08-12+ KNSA Malley Thomas Dir M - OptEx $0.00 -177.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Ordinary Shares 2025-08-13 M A 20,129 $10.36 32,675 D — —
2 Common Class A Ordinary Shares 2025-08-13 M A 30,000 $9.88 62,675 D — —
3 Common Class A Ordinary Shares 2025-08-13 S D 50,129 $33.32 12,546 D — — (F2) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $33.1301 and $33.50. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
4 Common Class A Ordinary Shares 2025-08-14 M A 18,760 $15.47 31,306 D — —
5 Common Class A Ordinary Shares 2025-08-14 M A 33,237 $14.33 64,543 D — —
6 Common Class A Ordinary Shares 2025-08-14 M A 26,236 $15.19 90,779 D — —
7 Common Class A Ordinary Shares 2025-08-14 S D 78,233 $33.09 12,546 D — — (F3) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.82 and $33.41. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
8 Common Class A Ordinary Shares 2025-08-12 S D 49,407 $32.40 12,546 D — — (F1) This transaction was executed in multiple trades through a broker-dealer at prices ranging between $32.06 and $32.685. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
9 Common Class A Ordinary Shares 2025-08-12 M A 21,959 $1.86 34,505 D — —
10 Common Class A Ordinary Shares 2025-08-12 M A 27,448 $3.80 61,953 D — —
11 Derivative Share Option 2025-08-12 M D 21,959 $0.00 0 D $1.86 · — to 2026-12-06 21,959 Class A Ordinary Shares (F5) The option is fully vested and exercisable.
12 Derivative Share Option 2025-08-12 M D 27,448 $0.00 0 D $3.80 · — to 2027-06-28 27,448 Class A Ordinary Shares (F5) The option is fully vested and exercisable.
13 Derivative Share Option 2025-08-13 M D 20,129 $0.00 0 D $10.36 · — to 2028-02-29 20,129 Class A Ordinary Shares (F5) The option is fully vested and exercisable.
14 Derivative Share Option 2025-08-13 M D 30,000 $0.00 0 D $9.88 · — to 2032-06-28 30,000 Class A Ordinary Shares (F5) The option is fully vested and exercisable.
15 Derivative Share Option 2025-08-14 M D 18,760 $0.00 0 D $15.47 · — to 2029-05-28 18,760 Class A Ordinary Shares (F5) The option is fully vested and exercisable.
16 Derivative Share Option 2025-08-14 M D 26,236 $0.00 0 D $15.19 · — to 2033-06-04 26,236 Class A Ordinary Shares (F5) The option is fully vested and exercisable.
17 Derivative Share Option 2025-08-14 M D 33,237 $0.00 0 D $14.33 · — to 2031-06-28 33,237 Class A Ordinary Shares (F5) The option is fully vested and exercisable.